TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from ...

A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

The quest for more effective cancer radiotherapy continues apace, with Telix Pharmaceuticals (ASX:TLX) today reporting “encouraging” preliminary results from its phase II study to treat recurrent high ...

The Mikey Strong Foundation will be holding its “Golf Fore A Cure” golf tournament on April 26, at Spessard Holland Golf ...

Common childhood infections once considered mere inconveniences may provide unexpected long-term benefits. Emerging research suggests certain illnesses ...

SAN DIEGO, CA, USA I April 17, 2025 I Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted ...

Calidi Biotherapeutics (NYSE American: CLDI) announced FDA clearance of its Investigational New Drug application for CLD-201, an allogeneic stem cell ...

Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, is pleased to announce the inclusion of the first patient in its phase I ...

Carlsbad, California Monday, April 14, 2025, 10:00 Hrs [IST] ...

Low-grade gliomas are tumours that arise from the support cells called glial cells within the brain, and tend to be slow growing, with current care focused on monitoring, surgery, radiosurgery ...